Egetis Therapeutics AB (publ) (STO:EGTX)
Sweden · Delayed Price · Currency is SEK 5.33
+0.06 (1.14%)
Jun 12, 2026, 5:29 PM CET
Egetis Therapeutics AB Market Cap
Egetis Therapeutics AB has a market cap or net worth of 2.46 billion as of June 12, 2026. Its market cap has increased by 122.47% in one year.
Market Cap
2.46B
Enterprise Value
2.39B
Revenue
63.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.33
Market Cap Chart
Since April 7, 2011, Egetis Therapeutics AB's market cap has increased from 224.89M to 2.46B, an increase of 994.55%. That is a compound annual growth rate of 17.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 2.46B | 16.65% |
| Dec 30, 2025 | 2.11B | -16.09% |
| Dec 30, 2024 | 2.51B | 54.03% |
| Dec 29, 2023 | 1.63B | 7.15% |
| Dec 30, 2022 | 1.52B | 37.56% |
| Dec 30, 2021 | 1.11B | -10.17% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hansa Biopharma AB | 3.28B |
| Vicore Pharma Holding AB | 2.91B |
| Flerie AB | 1.99B |
| Saniona AB | 1.80B |
| BioInvent International AB | 1.63B |
| Genovis AB (publ.) | 1.32B |
| Medivir AB | 926.51M |
| Infant Bacterial Therapeutics AB | 808.29M |